Lamassu Biotech, the North Carolina-based biopharmaceutical company that opened a Cleveland office last year, has received a $2.7 million grant from the National Institutes of Health to help develop its therapy for...
New ‘One Health’ Grant Could Help Man’s Best Friend with Groundbreaking Researchfor Presently Untreatable Condition, Provide Key Data for Human Treatment (CLEVELAND, OH) – Momentum continues to build for Lamassu...
Pioneering Research Will Help Drive Dual-Purpose Treatment for Life-Threatening Conditions in Both Humans and Man’s Best Friend (CLEVELAND, OH) – Man’s best friend may soon benefit from a new treatment,...